Related Experiment Video
Updated: Feb 27, 2026

Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct
Published on: April 1, 2022
Hypertriglyceridaemia-Associated Acute Pancreatitis: Risk Stratification, Drivers, and Prevention of Recurrence
Federica Fogacci1,2, Arrigo F G Cicero1,3
1Hypertension and Cardiovascular Risk Factors Research Centre, Medical and Surgical Sciences Department, Alma Mater Studiorum University of Bologna, 40100 Bologna, Italy.
Severe hypertriglyceridaemia is a major cause of acute pancreatitis. Management involves rapid reduction, lifestyle changes, and new RNA-targeted therapies for prevention.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Gastroenterology
Background:
- Hypertriglyceridaemia is a common cause of acute pancreatitis, particularly when triglyceride levels exceed 10 mmol/L.
- Risk is elevated at lower levels with chylomicronaemia, metabolic stress, or pregnancy.
- Understanding genetic vs. acquired causes is crucial for management.
Purpose of the Study:
- To review current evidence on hypertriglyceridaemia and acute pancreatitis.
- To discuss epidemiological, mechanistic, and management aspects.
- To highlight emerging therapies for severe hypertriglyceridaemia.
Main Methods:
- Literature review of contemporary evidence.
- Synthesis of data on epidemiology and pathophysiology.
- Summary of acute and long-term management strategies.
Main Results:
- Triglyceride levels >10 mmol/L significantly increase pancreatitis risk.
- Distinguishing genetic and secondary causes informs treatment.
- Insulin, therapeutic plasma exchange, lifestyle changes, and pharmacotherapy are key management tools.
Conclusions:
- Effective management of hypertriglyceridaemia is vital for preventing acute pancreatitis recurrence.
- Emerging RNA-targeted therapies show promise for high-risk patients.
- A multi-faceted approach is necessary for optimal patient outcomes.
Related Concept Videos
Acute Pancreatitis II: Clinical Manifestations and Management
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...

